Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 6Unknown 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 4Colorectal Neoplasms 3Pancreatic Neoplasms 1Liver Metastasis Colon Cancer 1Colonic Neoplasms 1

Interventions

Fluorouracil 80Oxaliplatin 72Leucovorin 66Irinotecan 60Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × FOLFOXIRI protocol × Clear all
NCT05081687 2023-10-11

BRAZIL-TNT

Hospital Israelita Albert Einstein

Phase 3 Unknown
150 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT03487939 2021-04-19

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

China Medical University, China

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02128425 2014-05-07

FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Unknown
162 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡